The primary challenge in developing the new drug is finding an effective treatment that addresses the fundamental cause of diabetes. Current treatments mainly focus on managing blood sugar levels and do not lead to a complete cure of the disease itself. Additionally, it is necessary to confirm the safety and efficacy of the new drug and obtain regulatory approval. This requires extensive clinical trials and rigorous data analysis.